1例川崎病休克综合征的早期识别和治疗
Early Recognition and Treatment of Kawasaki Disease Shock Syndrome in 1 Case
摘要: 目的：探讨川崎病休克综合征(KDSS)的早期识别及治疗。方法：回顾性分析我院1例KDSS患儿的临床表现、治疗过程。结果：患儿，男，5月1天，确诊为KD，病程第6天出现KDSS，给予抗休克、抗炎治疗，病程第13天出现消化道症状，给予补液、调理肠道菌群、保护肠粘膜等治疗后病情好转，医嘱出院。结论：对于KD患儿出现血流动力学不稳定现象，应立即考虑到KDSS，并给予积极治疗，减轻冠脉损害。
Abstract: Objective: To investigate the early recognition and treatment of Kawasaki disease shock syndrome. Method: The clinical manifestations and treatment course of a child with Kawasaki disease shock syndrome were analyzed retrospectively. Result: The patient, male, was diagnosed as Kawasaki disease on five months and one day, and Kawasaki disease shock syndrome appeared on the 6th day of the course of disease. He was given anti-shock and anti-inflammatory treatment. On the 13th day of the course of disease, the child developed digestive tract symptoms, and was treated with fluid rehydration, intestinal flora conditioning, intestinal mucosa protection and other treatments, after which his condition improved. The doctor ordered his to be discharged. Conclusion: Kawasaki disease shock syndrome should be considered immediately and treated actively in children with KD with hemodynamic instability to alleviate coronary artery damage.
文章引用：孙越, 高永伟, 李元霞. 1例川崎病休克综合征的早期识别和治疗[J]. 临床医学进展, 2021, 11(4): 1615-1621. https://doi.org/10.12677/ACM.2021.114232

参考文献

[1] 齐颖, 武宇辉, 等. 16例川崎病休克综合征临床分析[J]. 中国小儿急救医学, 2017, 24(12): 925-928.
[2] Pang, M.Y., Harris, J.E. and Eng, J.J. (2006) A Community-Based Upper Extremity Group Exercise Program Improves Motor Function and Performance of Functional Activities in Chronic Stroke: A Randomized Controlled Trial. Archives of Physical Medicine & Rehabilitation, 87, 1-9. [Google Scholar] [CrossRef] [PubMed]
[3] Kato, H., Koike, S., Yamamoto, M., et al. (1975) Coronary Aneurysms in Infants and Young Children with Acute Febrile Mucocutaneous Lymph Node Syndrome. The Journal of Pediatrics, 86, 892-898. [Google Scholar] [CrossRef] 
[4] 吕海涛. 川崎病休克综合征——儿科医师应重视的一种严重川崎病亚型. 中国小儿急救医学, 2020, 27(9): 657-660.
[5] Park, W.Y., et al. (2021) Clinical Aspects for Differential Diagnosis of Kawasaki Disease Shock Syndrome: A Case Control Study. BMC Pediatrics. [Google Scholar] [CrossRef] [PubMed]
[6] Newburger, J.W., Takahashi, M. and Burns, J.C. (2015) Kawasaki Disease. Journal of the American College of Cardiology, 67, 1738-1749. [Google Scholar] [CrossRef] [PubMed]
[7] 薛超超, 潘国权, 等. 不同血压类型川崎病患儿的临床特点分析. 医学研究杂志, 2017, 46(4): 78-82.
[8] Kanegaye, J.T., Wilder, M.S., Molkara, D., et al. (2009) Recognition of a Kawasaki Disease Shock Syndrome. Pediatrics, 123, 783-789. [Google Scholar] [CrossRef] [PubMed]
[9] 单鸣凤, 梅小丽, 等. 儿童川崎病休克综合征的临床特点及相关因素. 中华实用儿科临床杂志, 2018, 33(9): 668-672.
[10] Lin, M.T., Fu, C.M., Huang, S.K., et al. (2013) Population Based Study of Kawasaki Disease Shock Syndrome in Taiwan. The Pediatric Infectious Disease Journal, 32, 1384-1386. [Google Scholar] [CrossRef] 
[11] Chen, P.S., Chi, H., Huang, F.Y., et al. (2015) Clinical Manifestations of Kawasaki Disease Shock Syndrome: A Case-Control Study. Journal of Microbiology, Immunology and Infection, 48, 43-50. [Google Scholar] [CrossRef] [PubMed]
[12] Qiu, H.X., Xue, C.C., Chen, Q., et al. (2015) Clinical Manifestations and Risk Factors of Kawasaki Disease Shock Syndrome. Chinese Journal of Critical Care Medicine, 8, 230-234.
[13] 李丰, 张园海, 邵兰, 等. 川崎病并发休克6例临床分析. 临床儿科杂志, 2012, 30(10): 939-941.
[14] 泮思林, 刘芳, 罗刚, 等. 日本川崎病诊断指南第6次修订版. 中国实用儿科杂志, 2020, 35(11): 846-849.
[15] Lamagni, T.L., Darenberg, J., Luca-Harari, B., et al. (2008) Epidemiology of Severe Strep Tococcus Pyogenes Disease in Europe. Journal of Clinical Microbiology, 46, 2359-2367. [Google Scholar] [CrossRef] 
[16] 刘小惠, 彭宇, 蔡素芬. 川崎病1817例临床分析. 江西医学, 2019, 54(7): 806-807.
[17] 蒋道菊, 黄萍, 张丽, 等. 川崎病休克综合征的研究进展. 中华儿科杂志, 2016, 54(12): 961-963.
[18] 骆盈莹. 川崎病患儿心血管损害生物学标志物研究进展. 蛇志, 2020, 32(4): 492-494.
[19] Natterer, J., Perez, M.H. and Dibernardo, S. (2012) Capillary Leak Leading to Shock in Kawasaki Disease without Myocardial Days Function. Cardiology in the Young, 22, 349-352. [Google Scholar] [CrossRef] 
[20] Dominguez, S.R., Friedman, K., Seewald, R., et al. (2008) Kawasaki Disease in a Pediatric Intensive Care Unit: A Case-Control Study. Pediatrics, 122, 786-790. [Google Scholar] [CrossRef] [PubMed]
[21] 仇慧仙, 薛超超, 等. 川崎病休克综合征的临床特点及危险因素分析. 中华危重症医学杂志, 2015, 8(4): 230-234.
[22] Terai, M., Honda, T., Yasukawa, K., et al. (2003) Prognostic Impact of Vascular Leakage in Acute Kawasaki Disease. Circulation, 108, 325-330. [Google Scholar] [CrossRef] 
[23] Wang, W., Zhu, W.H., Qi, Y.Q., et al. (2012) Cardiogenic Shock: Do Not for Get the Possibility of Kawasaki Disease. Turkish Journal of Pediatrics, 54, 86-89.
[24] Checchia, P.A., Borensztajn, J. and Shulman, S.T. (2001) Circulating Cardiac Troponin I Levels in Kawasaki Disease. Pediatric Cardiology, 22, 102-106. [Google Scholar] [CrossRef] [PubMed]
[25] Shulmam, S.T. and Rowley, A.H. (2015) Kawasaki Disease: Insights into Pathogenesis and Approaches to Treatment. Nature Reviews Rheumatology, 11, 475-482. [Google Scholar] [CrossRef] [PubMed]
[26] Verdoni, L., Mazza, A., Gervasoni, A., et al. (2020) An Outbreak of Severe Kawasaki-Like Disease at the Italian Epicentre of the SARS-CoV-2 Epidemic: An Observational Cohort Study. The Lancet, 395, 1771-1778. [Google Scholar] [CrossRef] 
[27] Brogan, P.A., Shah, V., Klein, N., et al. (2004) Vbeta-Restricted T Cell Adherence to Endothelial Cells: A Mechanism for Superantigen Dependent Vascular Injury. Arthritis & Rheumatology, 50, 589-597. [Google Scholar] [CrossRef] [PubMed]
[28] Matsubara, K. and Fukaya, T. (2007) The Role of Superantigens of Group A Streptococcus and Staphylococcus aureus in Kawasaki Disease. Current Opinion in Infectious Diseases, 20, 298-303. [Google Scholar] [CrossRef] 
[29] Mitani, Y., Sawada, H., Hayakawa, H., et al. (2005) Elevated Levels of High-Sensitivity C-Reactive Protein and Serum Amyloid-A Late after Kawasaki Disease: Association between Inflammation and Late Coronary Sequelae in Kawasaki Disease. Circulation, 111, 38-43. [Google Scholar] [CrossRef] 
[30] Ou, C.Y., Tseng, Y.F., Lee, C.L., et al. (2009) Significant Relationship between Serum High-Sensitivity C-Reactive Protein, High Density Lipoprotein Cholesterol Levels and Children with Kawasaki Disease and Coronary Artery Lesions. Journal of the Formosan Medical Association, 108, 719-724. [Google Scholar] [CrossRef] 
[31] 刘力. 川崎病休克综合征的早期识别与处理. 中国小儿急救医学, 2020, 27(5): 324-329.
[32] Gatterre, P., Oualha, M., Dupic, L., et al. (2012) Kawasaki Disease: An Unexpected Etiology of Shock and Multiple Organ Dysfunction Syndrome. Intensive Care Medicine, 38, 872-878. [Google Scholar] [CrossRef] [PubMed]
[33] 李艳蝶, 郭莉, 等. 川崎病休克综合征临床特征及外周血细胞因子水平分析. 浙江医学, 2017, 39(21): 1852-1855.
[34] Tremoulet, A.H., Best, B.M., Song, S., et al. (2008) Resistance to Intravenous Immunoglobulin in Children with Kawasaki Disease. The Journal of Pediatrics, 153, 117-121. [Google Scholar] [CrossRef] [PubMed]
[35] Kuo, H.C., Yang, Y.L., Chuang, J.H., et al. (2012) Inflammation-Induced Hepcidin Is Associated with the Development of Anemia and Coronary Artery Iesions in Kawasaki Disease. Journal of Clinical Immunology, 32, 746-752. [Google Scholar] [CrossRef] [PubMed]
[36] 王利, 耿玲玲, 李小青. 川崎病休克综合征1例. 中华临床医师杂志, 2020, 14(3): 238-240.
[37] 阚璇, 吴德静, 等. 川崎病休克综合征的临床研究进展. 天津医药, 2018, 46(6): 670-672.
[38] Newburger, J.W., Sanders, S.P., Burns, J.C., et al. (1989) Left Ventricular Contractility and Function in Kawasaki Syndrome. Effect of Intravenous Gamma-Globulin. Circulation, 79, 1237-1246. [Google Scholar] [CrossRef] 
[39] 刘芳, 赵趣鸣, 等. MDT在重症川崎病中的应用. 中华医学信息导报, 2020, 35(24): 21.
[40] Qiu, H., Li, C., He, Y., et al. (2019) Association between Left Ventricular Rejection Fraction and Kawasaki Disease Shock Syndrome. Cardiology in the Young, 29, 178-184. [Google Scholar] [CrossRef] 
[41] Gamez-Gonzalez, L.B., Moribe-Quintero, I., Cisneros-Castolo, M., et al. (2018) Kawasaki Disease Shock Syndrome: Unique and Severe Subtype of Kawasaki Disease. Pediatrics International, 60, 781-790. [Google Scholar] [CrossRef] [PubMed]

为你推荐